LA SCCHN
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT01303237) | Merck KGaA, Darmstadt, Germany | 2011-02-28 |
Track LA SCCHN automatically
Every clearance here is in the API, with alerts when new ones post.